James Frederick is a practicing Physician Associate (PA-C, MMSc) who studied at Yale University. He also has a bachelor’s degree in creative writing and English Literature from the University of Colorado. He specializes in writing medical content that is approachable, readable and enjoyable. He has a strong background in research, physiology, pharmacotherapy, emergency medicine and critical care medicine. In his free time, he enjoys spending time camping and traveling with his wife and dog.
A new study suggests that mutations in the BAP1 gene, a tumor suppressor that has been implicated in tumor development in several different types of cancer, may improve clinical stratification ... Read more
The point at which doctors assess biomarkers of mesothelioma patients’ response to a combination of chemotherapy and immunotherapy is crucial to obtaining a clear picture of how the patients are doing, ... Read more
Despite advances in diagnostic tools available to scientists, electron microscopy (EM) remains important in the diagnosis of many diseases, including malignant pleural mesothelioma (MPM). This is according to an article ... Read more
New research suggests that personalized treatment options based on a patient’s unique genetic biomarkers could lead to improved outcomes in cancer patients, including those suffering from mesothelioma. The study, “Clinical-pharmacogenetic ... Read more